Gupta A, Bhosale R, Kinikar A, Gupte N, Bharadwaj R, Kagal A, Joshi S, Khandekar M, Karmarkar A, Kulkarni V, Sastry J, Mave V, Suryavanshi N, Thakar M, Kulkarni S, Tripathy S, Sambarey P, Patil S, Paranjape R, Bollinger RC, Jamkar A; Six Week Extended-Dose Nevirapine (SWEN) India Study Team.Interview with Dr. Anneke Hesseling – Part Three
TB R&D Weekly Update: TB Vaccine Demonstrates Protection Pre- and Post-exposure
Aagaard C, Hoang T, Dietrich J, Cardona PJ, Izzo A, Dolganov G, Schoolnik GK, Cassidy JP, Billeskov R, Andersen P. Interview with Dr. Anneke Hesseling – Part Two
Stop TB Partnership Announces New Executive Secretary
TB R&D Weekly Update: Stepwise Mutation in Clinical Isolates Supports Current TB Therapy
Saunders NJ, Urmi HT, Thomson ML, Doig C, Laurenson IF, Blaxter ML.Treating Latent TB in the Elderly Poses Greater Risk
Several news agencies reported on an article that appeared in the TB R&D Weekly Update: PA-824 Exhibits Time-Dependent Activity in Mice
Ahmad Z, Peloquin CA, Singh RP, Derendorf H, Tyagi S, Ginsberg A, Grosset JH, Nuermberger EL.Interview with Dr. Anneke Hesseling – Part One
TB News in Brief
Pages
